HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Srikrishna Sirivella Isaac Gielchinsky Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sirivella, S. Articles by Gielchinsky, I. Search for Related Content PubMed PubMed Citation Articles by Sirivella, S. Articles by Gielchinsky, I. Related Collections Coronary disease Valve disease

Results of Coronary Bypass and Valve Operations for Mitral Valve Regurgitation

Department of Cardiovascular and Thoracic Surgery, Newark Beth Israel Medical Center, University of Medicine & Dentistry of New Jersey, Newark, USA

For reprint information contact: Isaac Gielchinsky, MD, Tel: 1 973 763 1547, Fax: 1 973 763 7290, Email: igielchinsky{at}optonline.net, 685 Long View Road, South Orange, New Jersey 07079, USA.

Combined coronary bypass grafting and valve procedures for mitral valve regurgitation result in poor outcomes, but the impact of the etiology of valve regurgitation on operative and long-term outcomes is not well defined. A retrospective analysis of 468 patients who had combined coronary bypass grafting and valve operations for mitral regurgitation showed that 78% had valve repairs and 22% had replacements for ischemic (45%) or degenerative (55%) disease. Predictors of operative mortality were ischemic mitral regurgitation, failure to use the internal mammary artery for grafting, severe coronary disease, acute myocardial infarction, low ejection fraction, advanced heart failure, emergency operation, and mitral valve replacement. The 5-year survival rates for propensity-matched patients with ischemic or degenerative disease were similar (66%). Low ejection fraction (< 35%), advanced age (> 67 years), valve replacement surgery, residual mitral regurgitation, and severe coronary artery disease were predictors of poor long-term outcome. Although the operative outcomes of ischemic mitral regurgitation were poor compared to those of degenerative disease, the long-term survival was similar in both groups of propensity-matched patients. Left ventricular remodeling, an optimal valve procedure without residual mitral regurgitation, and left ventricular function are more important determinants of long-term outcome than the etiology of valve regurgitation.